-
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
26 Apr 2025 14:00 GMT
… 2 (NCT05951179) is a Phase 2 open-label trial assessing … Invasive Bladder Cancer: Developing Drugs and Biological Products for … of existing or future clinical trials (including reporting data from … non-clinical studies and clinical trials and the timing of …
-
Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis
26 Apr 2025 08:00 GMT
… -blind, placebo-controlled, Phase II study which enrolled 518 … Osteoarthritis: a Randomised Controlled Phase II Trial. Authors: Conaghan, … 04 has completed a Phase II clinical trial in more than 500 … the market opportunity for drugs that treat osteoarthritis …
-
Promising Outcomes Reported from MD Anderson Clinical Trials at AACR Conference
25 Apr 2025 17:46 GMT
… stem from pioneering clinical trials focusing on personalized cancer … target toxicities. Their Phase II prospective trial enrolled 121 … for an upcoming Phase II trial testing combination regimens … drug targeting in solid tumors. With upcoming Phase II …
-
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
25 Apr 2025 13:00 GMT
… its Phase 2 ASPEN-03 and ASPEN-04 clinical trials. The … in HNSCC, multiple clinical trials of evorpacept in combination … have granted Orphan Drug Designation for this indication … preclinical studies and clinical trials, results of clinical trials, research and …
-
NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1
25 Apr 2025 06:00 GMT
… to Immune Checkpoint -
Clinical Trial Design and Interim … from the ongoing ImmunoNET Phase II trial of its … our mission to develop drugs that overcome therapy resistance … Pharma is currently conducting four clinical trials: GyNET (NCT04652076), ImmunoNET …
-
Investigational Probiotic Drug Gains FDA Support for Phase 2 Obesity Trial
24 Apr 2025 23:56 GMT
… on Northstrive Biosciences’ Investigational New Drug (IND) application for the … was adequate to initiate a phase 2 clinical trial.
"This positive reinforcement … EL-22 in anticipation of clinical trials.
Reference: Northstrive Biosciences Announces …
-
Redefining the future of clinical trials in oncology
24 Apr 2025 22:54 GMT
… strategies for clinical trial success in oncology at the 12th Annual Clinical Trials in … research
The clinical trials operation stream will dive into optimisation of clinical trial execution … oncology drugs from bench to bedside, with a focus on Phase II and …
-
Sanofi axes development of oral TNF inhibitor as monotherapy following Phase II fail
24 Apr 2025 22:54 GMT
… results from the SPECIFIC-PSO Phase II study (NCT06073119) in … in various diseases.
The Phase II randomised, double-blind, placebo … .
The drug is also being investigated in Phase II trials in … , the parent company of Clinical Trials Arena, Humira hit its …
-
Hightide Therapeutics To Showcase New Analyses Of Phase 2 MASH/T2DM Studies Of Berberine Ursodeoxycholate (HTD1801) And Pre-Clinical Results Of Rimtoregtide (HTD4010) In Presentations At EASL Congress 2025
24 Apr 2025 20:38 GMT
… -hoc analyses of two Phase 2 clinical studies of berberine … A completed Phase 1 clinical trial of HTD4010 in healthy … mid-to-late-stage clinical trials including therapies for metabolic … HighTide's lead drug candidate, received Fast Track designation …
-
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
24 Apr 2025 17:00 GMT
… to execute a Phase II clinical trial in patients with … therapies @ Sarcopenia Clinical Trials Sarcopenia Therapeutics Assessment … Assessment
5.
Sarcopenia Clinical Trial Therapeutics
6.
Sarcopenia … trends, in emerging drugs, and competitive strategies. …